Pepinemab
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Pepinemab, covering 2022-04-26 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer [Phase 1]